1
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T31899 | FY26 | FY 26,FY-26 | |
FY26 is a potent Os(II) anticancer drug candidate, exerts its activity by generating reactive oxygen species and disrupting the redox balance in cancer cells Coadministration of FY26 and nontoxic doses of L-BSO allows th... |